A modular assembly pH-sensitive charge reversal siRNA delivery system
Source abstract
Abstract
Cationic lipids and polymers are the most common non-viral vectors for siRNA delivery; however, their intense positively charged character may give rise to serum-triggered aggregation, immune activation, inflammation stimulation and grievous toxicity. An ocean of charge shielding strategies is exploited, but the currently available siRNA delivery systems still remain ungratified and deficient. Herein, we developed a facile modular assembly strategy for a pH-sensitive charge reversal siRNA delivery system (PC), which can be easily obtained by adjusting the ratios of positively and negatively charged modules. This PC is electronegative at neutral pH and reverses to electropositive at an acidic pH value with increased tumor cellular uptake. Also, the PC can promote efficient intracellular release and cytoplasmic distribution of siRNA, due to its fusogenic potential with the lysosome membrane. Moreover, the PC loaded with siRNA targeting survivin mRNA (cpusiRNA2) specifically down-regulated the expression of survivin, possessing remarkable tumor therapeutic efficacy in vitro and in vivo. Accordingly, this handy and effective assembly strategy would provide a promising platform for the design of siRNA delivery systems in cancer therapy.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases
Center of Advanced Pharmaceuticals and Biomaterials
China Pharmaceutical University
Nanjing 210009
China
Funding
National Natural Science Foundation of China · Ministry of Education of the People's Republic of China · State Administration of Foreign Experts Affairs
References (32)
Show source-provided references
1. Morrison · Nat. Rev. Drug Discovery · 2018 · 17 · 15610.1038/nrd.2018.20 ↗
2. Gorski · Nat. Rev. Mol. Cell. Biol. · 2017 · 18 · 21510.1038/nrm.2016.174 ↗
3. Liao · Biomater. Sci. · 2016 · 4 · 105110.1039/C6BM00204H ↗
4. Keles · Biomater. Sci. · 2016 · 4 · 129110.1039/C6BM00441E ↗
5. Roh · Angew. Chem., Int. Ed. · 2016 · 55 · 334710.1002/anie.201508978 ↗
6. Lee · Adv. Funct. Mater. · 2015 · 25 · 127910.1002/adfm.201403680 ↗
7. Rezaee · J. Controlled Release · 2016 · 236 · 110.1016/j.jconrel.2016.06.023 ↗
8. Liu · Nanoscale · 2015 · 7 · 386710.1039/C4NR04759A ↗
9. Loh · Biomater. Sci. · 2016 · 4 · 7010.1039/C5BM00277J ↗
10. Yin · Nat. Rev. Genet. · 2014 · 15 · 54110.1038/nrg3763 ↗
11. Xu · Biomater. Sci. · 2016 · 4 · 164610.1039/C6BM00601A ↗
12. Liu · Biomater. Sci. · 2018 · 6 · 159210.1039/C8BM00263K ↗
13. Lin · Biomater. Sci. · 2014 · 2 · 100710.1039/C3BM60325C ↗
14. Lee · Adv. Drug Delivery Rev. · 2016 · 104 · 210.1016/j.addr.2016.05.010 ↗
15. Ding · Angew. Chem., Int. Ed. · 2018 · 57 · 306410.1002/anie.201711242 ↗
16. Takemoto · Angew. Chem., Int. Ed. · 2013 · 52 · 621810.1002/anie.201300178 ↗
17. Xu · Angew. Chem., Int. Ed. · 2016 · 55 · 709110.1002/anie.201601273 ↗
18. Kim · Adv. Drug Delivery Rev. · 2016 · 104 · 6110.1016/j.addr.2016.06.011 ↗
19. Tang · Adv. Funct. Mater. · 2016 · 26 · 603310.1002/adfm.201601703 ↗
20. Guan · Nano Lett. · 2016 · 16 · 682310.1021/acs.nanolett.6b02536 ↗
21. Sun · J. Am. Chem. Soc. · 2015 · 137 · 600010.1021/jacs.5b01435 ↗
22. Tseng · Nat. Commun. · 2015 · 6 · 645610.1038/ncomms7456 ↗
23. Ju · Angew. Chem., Int. Ed. · 2014 · 53 · 625310.1002/anie.201311227 ↗
24. Li · Angew. Chem., Int. Ed. · 2012 · 51 · 286410.1002/anie.201107144 ↗
25. Obata · Bioconjugate Chem. · 2008 · 19 · 105510.1021/bc700416u ↗
26. Zhang · Mol. Pharmaceutics · 2011 · 8 · 75810.1021/mp100366h ↗
27. Dudleenamjil · J. Gen. Virol. · 2010 · 91 · 303210.1099/vir.0.024133-0 ↗
28. Koivusalo · J. Cell Biol. · 2010 · 189 · 38510.1083/jcb.20090808620100331c ↗
29. Fazlollahi · Nanomedicine · 2011 · 7 · 58810.1016/j.nano.2011.01.008 ↗
30. Mo · Adv. Mater. · 2012 · 24 · 365910.1002/adma.201201498 ↗
31. Lu · Cancer Biother. Radiopharm. · 2008 · 23 · 72710.1089/cbr.2008.0503 ↗
32. Park · Angew. Chem., Int. Ed. · 2016 · 55 · 458210.1002/anie.201510844 ↗